Ocular adverse events may be linked with immune checkpoint inhibitors

A new IRIS Registry study describes the rate of ocular immune-related adverse events after treatment with immune checkpoint inhibitors.
Source: AAO

Posted in: Uncategorized

Leave a response

658 Malta Ave, Suite 101 Malta, NY 12020 (518) 580-0553